Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics

Journal Title: Archives of Medical Science - Year 2007, Vol 3, Issue 1

Abstract

Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the trial with cholinesterase inhibitors seems to be legitimated. Material and methods: Five patients with PD (with or without dementia) complicated by VH and unresponsive to atypical antipsychotics were offered a 12-week, open-label trial of a cholinesterase inhibitor. Results: All 5 subjects completed the trial with no major adverse effects and, noteworthy, no discontinuations due to adverse events. VH resolved in 4 subjects and were markedly diminished in one person. Neither changes in UPDRS scores nor exaggeration of subjective complaints about extrapyramidal symptoms were noted during treatment. Conclusions: Cholinesterase inhibitors, rivastigmine or donepezil, might represent a useful alternative to antipsychotics for patients with PD accompanied by VH even in the absence of dementia.

Authors and Affiliations

Tomasz Sobow

Keywords

Related Articles

REVIEW PAPER Trigemino-cardiac reflex: A recently discovered “oxygen-conserving” response? The potential therapeutic role of a physiological reflex

The trigemino-cardiac reflex (TCR) is defined as a sudden onset of parasympathetic dysrhythmia, sympathetic hypotension, apnea or gastric hypermotility during the stimulation of any of the sensory branches of the trige...

HLA-B27 (antigen) in retroperitoneal fibrosis in a family

Idiopathic retroperitoneal fibrosis is a rare disease of undetermined aetiology. It is important to distinguish this entity from retroperitoneal fibrosis secondary to malignancy or specific inflammatory disease. There ha...

Download PDF file
  • EP ID EP154668
  • DOI -
  • Views 190
  • Downloads 0

How To Cite

Tomasz Sobow (2007). Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics . Archives of Medical Science, 3(1), 69-72. https://www.europub.co.uk/articles/-A-154668